465
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Novel prostaglandin receptor modulators: a patent review (2002 – 2012) – part I: non-EP receptor modulators

, , &
Pages 47-77 | Published online: 14 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (11)

Luying Chen, Ge Yan & Tomohiko Ohwada. (2022) Building on endogenous lipid mediators to design synthetic receptor ligands. European Journal of Medicinal Chemistry 231, pages 114154.
Crossref
Xianhai Huang, Jason Brubaker, Wei Zhou, Purakkattle J. Biju, Li Xiao, Ning Shao, Ying Huang, Li Dong, Zhidan Liu, Rema Bitar, Alexei Buevich, Joon Jung, Scott L. Peterson, John W. Butcher, Joshua Close, Michelle Martinez, Rachel N. MacCoss, Hongjun Zhang, Scott Crawford, Kevin D. McCormick, Robert Aslanian, Ravi Nargund, Craig Correll, Francois Gervais, Hongchen Qiu, Xiaoxin Yang, Charles Garlisi, Diane Rindgen, Kevin M. Maloney, Phieng Siliphaivanh & Anandan Palani. (2018) Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma. ACS Medicinal Chemistry Letters 9:7, pages 679-684.
Crossref
Ewgenij Proschak, Pascal Heitel, Lena Kalinowsky & Daniel Merk. (2017) Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery. Journal of Medicinal Chemistry 60:13, pages 5235-5266.
Crossref
Anna Cooper, Sameek Singh, Sarah Hook, Joel D. A. Tyndall & Andrea J. Vernall. (2017) Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors. Pharmacological Reviews 69:3, pages 316-353.
Crossref
Roopesh Singh Gangwar, Nadine Landolina, Ludovica Arpinati & Francesca Levi-Schaffer. (2017) Mast cell and eosinophil surface receptors as targets for anti-allergic therapy. Pharmacology & Therapeutics 170, pages 37-63.
Crossref
David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois & Steven J. Charlton. (2016) Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy. Molecular Pharmacology 89:5, pages 593-605.
Crossref
Daniel Merk, Martina Zettl, Dieter Steinhilber, Oliver Werz & Manfred Schubert-Zsilavecz. (2015) Pirinixic acids: flexible fatty acid mimetics with various biological activities. Future Medicinal Chemistry 7:12, pages 1597-1616.
Crossref
Van T. Luu, Jean-Yves Goujon, Christian Meisterhans, Matthias Frommherz & Carsten Bauer. (2015) Synthesis of a high specific activity methyl sulfone tritium isotopologue of fevipiprant (NVP-QAW039). Journal of Labelled Compounds and Radiopharmaceuticals 58:5, pages 188-195.
Crossref
Z. Diamant, P. N. Sidharta, D. Singh, B. J. O'Connor, R. Zuiker, B. R. Leaker, M. Silkey & J. Dingemanse. (2014) Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics. Clinical & Experimental Allergy 44:8, pages 1044-1052.
Crossref
Michael G. Johnson, Jim (Jiwen) Liu, An-Rong Li, Bettina van Lengerich, Sophie Wang, Julio C. Medina, Tassie L. Collins, Jay Danao, Lisa Seitz, Angela Willee, Warren D’Souza, Alison L. Budelsky, Peter W. Fan & Simon G.W. Wong. (2014) Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD2 receptors CRTH2 and DP. Bioorganic & Medicinal Chemistry Letters 24:13, pages 2877-2880.
Crossref
Neelu Kaila, Bruce Follows, Louis Leung, Jennifer Thomason, Adrian Huang, Alessandro Moretto, Kristin Janz, Michael Lowe, Tarek S. Mansour, Cedric Hubeau, Karen Page, Paul Morgan, Susan Fish, Xin Xu, Cara Williams & Eddine Saiah. (2014) Discovery of Isoquinolinone Indole Acetic Acids as Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases. Journal of Medicinal Chemistry 57:4, pages 1299-1322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.